Hepatic loss of AATF attenuates MASH by suppressing AKT–mTORC1 signaling and reprogramming lipid metabolism
Our findings reveal a previously unrecognized role of AATF as a central regulator of hepatic lipid metabolism in MASH, acting through the AKT-mTORC1 signaling pathway, and establish its inhibition as a promising therapeutic strategy for the treatment of metabolic liver disease.
Authors
- Diwakar Suresh
- Divya P. Kumar (ORCID: https://orcid.org/0000-0001-5935-379X)
- Akshatha N. Srinivas (ORCID: https://orcid.org/0000-0001-5524-2312)
- Gopalkrishna Ramaswamy
- Divya P. Kumar
- Manju Moorthy
- Shivaram P. Singh
- Deepak Suvarna
- Suma M. Nataraj
Institutions
- JSS Academy of Higher Education and Research (IN)
Publication Details
- Journal
- Molecular Medicine
- Published
- 2026-01-13
- DOI
- https://doi.org/10.1186/s10020-025-01417-w
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00